EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Huanglian Jiedu decoction alleviates ischemia‐induced cerebral injury in rats by mitigating NET formation and activiting GABAergic synapses

Youxiang Cui, Mingyue Cui, Leilei Wang, Ning Wang, Yao Chen, Shuquan Lv, Limin Zhang, Congai Chen, Yanwen Yang, Feng Wang, Lichun Wang, Huantian Cui iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Youxiang Cui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Neurological Rehabilitation, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Synapses, Rats, Sprague-Dawley, Brain Ischemia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huanglian Jiedu decoction (HLJD) has been used to treat ischemic stroke in clinic. However, the detailed protective mechanisms of HLJD on ischemic stroke have yet to be elucidated. The aim of this study is to elucidate the underlying pharmacological mechanisms of HLJD based on the inhibition of neuroinflammation and the amelioration of nerve cell damage. A middle cerebral artery occlusion reperfusion (MCAO/R) model was established in rats and received HLJD treatment. Effects of HLJD on neurological function was assessed based on Bederson's score, postural reflex test and asymmetry score. 2, 3, 5‐Triphenyltetrazolium chloride (TTC) staining, Hematein and eosin (HE) and Nissl staining were used to observe the pathological changes in brain. Then, transcriptomics was used to screen the differential genes in brain tissue in MCAO/R model rats following HLJD intervention. Subsequently, the effects of HLJD on neutrophil extracellular trap (NET) formation‐related neuroinflammation, gamma‐aminobutyric acid (GABA)ergic synapse activation, nerve cell damage and proliferation were validated using immunofluorescence, western blot and enzyme‐linked immunosorbent assay (ELISA). Our results showed that HLJD intervention reduced the Bederson's score, postural reflex test score and asymmetry score in MCAO/R model rats. Pathological staining indicated that HLJD treatment decreased the cerebral infarction area, mitigated neuronal damage and increased the numbers of Nissl bodies. Transcriptomics suggested that HLJD affected 435 genes in MCAO/R rats. Among them, several genes involving in NET formation and GABAergic synapses pathways were dysregulated. Subsequent experimental validation showed that HLJD reduced the MPO + CitH3 + positive expression area, reduced the protein expression of PAD4, p‐P38/P38, p‐ERK/ERK and decreased the levels of IL‐1β, IL‐6 and TNF‐α, reversed the increase of Iba1 + TLR4 + , Iba1 + p65 + and Iba1 + NLRP3 + positive expression area in brain. Moreover, HLJD increased GABA levels, elevated the protein expression of GABRG1 and GAT3, decreased the TUNEL positive expression area and increased the Ki67 positive expression area in brain. HLJD intervention exerts a multifaceted positive impact on ischemia‐induced cerebral injury in MCAO/R rats. This intervention effectively inhibits neuroinflammation by mitigating NET formation, and concurrently improves nerve cell damage and fosters nerve cell proliferation through activating GABAergic synapses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalSynapsesRats, Sprague-DawleyBrain IschemiaAnimalsRatsMaleDisease Models, AnimalGABAergic Neuronsgamma-Aminobutyric AcidInfarction, Middle Cerebral ArteryReperfusion InjuryNeuroprotective AgentsBrain

Stichwörter der Autor:innen

GABAergic synapsesHuanglian Jiedu decoctionischemia‐induced cerebral injuryneutrophil extracellular trap formationtraditional Chinese medicinetranscriptomics

Substanzen

Drugs, Chinese Herbalhuanglian-jie-du decoctiongamma-Aminobutyric AcidNeuroprotective Agents

Autor:innen und Institutionen

  • Key Laboratory of Neurological Rehabilitation, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China.
  • First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China.
  • Beijing University of Chinese Medicine, Beijing, China.

ORCID-Profile: Huantian Cui

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cui, Y., Cui, M., Wang, L., Wang, N., Chen, Y., Lv, S., Zhang, L., Chen, C., Yang, Y., Wang, F., Wang, L., & Cui, H. (2024). Huanglian Jiedu decoction alleviates ischemia‐induced cerebral injury in rats by mitigating NET formation and activiting GABAergic synapses. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18528

Vancouver

Cui Y, Cui M, Wang L, Wang N, Chen Y, Lv S, et al. Huanglian Jiedu decoction alleviates ischemia‐induced cerebral injury in rats by mitigating NET formation and activiting GABAergic synapses. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18528

BibTeX
@article{Cui2024,
  author = {Cui, Youxiang and Cui, Mingyue and Wang, Leilei and Wang, Ning and Chen, Yao and Lv, Shuquan and Zhang, Limin and Chen, Congai and Yang, Yanwen and Wang, Feng and Wang, Lichun and Cui, Huantian},
  title = {Huanglian Jiedu decoction alleviates ischemia‐induced cerebral injury in rats by mitigating NET formation and activiting GABAergic synapses},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18528}
}
Kostenlos starten →